Frequency and Incidence of Bacterial Infection in the Female Reproductive System

• Authors: Odunayo Blessing Adesina , Esther ibiyemi Oke
• Languages of publication: EN

Abstracts

EN

This study aimed to assess the frequency and incidence of bacterial infections in the female reproductive system, particularly focusing on vaginal infections. The research involved the analysis of high vaginal swab and urine samples from a population of women presenting with various gynecological concerns. Notably, the study investigated the prevalence of bacterial vaginosis (BV), candida, and trichomonas in both symptomatic and asymptomatic cases. Several crucial findings emerged from the research. First, there was a high prevalence of pus cells (90.0%) observed, which could indicate underlying inflammation or infection. Concurrently, yeast cells were detected in a substantial 86.0% of cases, suggesting a notable presence of yeast infections among the study participants. Age-wise analysis revealed an intriguing pattern, with the 26-30 age group standing out in terms of significant bacterial growth. This age group recorded the highest count of samples with such growth (15), potentially highlighting a higher susceptibility to bacterial infections within this demographic. Candida albicans emerged as a dominant microorganism with a frequency of 47.6%, implying a significant presence of this yeast and potential fungal infections within the study population. The study examined antibiotic sensitivity patterns among bacterial isolates. This analysis underscored the need for tailored antibiotic treatments, as there were varying degrees of sensitivity and resistance to different antibiotics among the isolates. The findings emphasize the importance of personalized approaches to antibiotic therapy based on the specific bacterial species and their susceptibility patterns. This study contributes valuable insights into the frequency and incidence of bacterial infections in the female reproductive system. The prominent tables, including the prevalence of pus and yeast cells, the age-specific susceptibility to bacterial infections, the dominance of C. albicans, and the antibiotic sensitivity patterns, collectively enhance our understanding of women's reproductive health and emphasize the significance of individualized medical interventions.

Keywords

EN

Antibiotic sensitivity; Bacterial infections; Candida albicans; Pus cells; Vaginal infections; Yeast infections

Discipline

• MICROBIOLOGY: MICROBIOLOGY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2024
• Volume: 52
• Pages: 126-138

Contributors

author

Odunayo Blessing Adesina

• Department of Microbiology, Faculty of Pure and Applied Sciences, Higher Institute of Communication, Organization, and Management (ISCOM), University Benin Republic, Lot 4390, Senade - Akpakpa, Cotonou, Republic Benin

author

Esther ibiyemi Oke

• Department of Microbiology, Faculty of Pure and Applied Sciences, Higher Institute of Communication, Organization, and Management (ISCOM), University Benin Republic, Lot 4390, Senade - Akpakpa, Cotonou, Republic Benin

References

• [1] Al-Nasiry S, Ambrosino E, Schlaepfer M, Morré SA, Wieten L, Voncken JW, et al. The interplay between reproductive tract microbiota and immunological system in human reproduction. Front Immunol. (2020) 11: 378. doi: 10.3389/fimmu.2020.00378
• [2] Amabebe E, Anumba DOC. Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front Immunol. (2020) 11: 2184. doi: 10.3389/fimmu.2020.02184
• [3] Brandão P, Gonçalves-Henriques M. The impact of female genital microbiota on fertility and assisted reproductive treatments. J Fam Reprod Health. (2020) 14: 131–149. doi: 10.18502/jfrh.v14i3.4666
• [4] Byrne EH, Farcasanu M, Bloom SM, Xulu N, Xu J, Hykes BL. Antigen presenting cells link the female genital tract microbiome to mucosal inflammation, with hormonal contraception as an additional modulator of inflammatory signatures. Front Cell Infect Microbiol. (2021) 11: 733619. doi: 10.3389/fcimb.2021.733619
• [5] Campisciano G, Zanotta N, Licastro D, De Seta F, Comar M. In vivo microbiome and associated immune markers: new insights into the pathogenesis of vaginal dysbiosis. Sci Rep. (2018) 8: 2307. doi: 10.1038/s41598-018-20649-x
• [6] Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Factories. (2020) 19: 203. doi: 10.1186/s12934-020-01464-4
• [7] Dabee S, Passmore J-AS, Heffron R, Jaspan HB. The complex link between the female genital microbiota, genital infections, and inflammation. Infect Immun. (2021) 89: e00487–20. doi: 10.1128/IAI.00487-20
• [8] Fichorova RN, Morrison CS, Chen P-L, Yamamoto HS, Govender Y, Junaid D. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections inwomen of reproductive age. PLoS ONE (2020) 15: e0224359. doi: 10.1371/journal.pone.0224359
• [9] Happel A-U, Varsani A, Balle C, Passmore J-A, Jaspan H. The vaginal virome—balancing female genital tract bacteriome, mucosal immunity, and sexual and reproductive health outcomes? Viruses. (2020) 12: 832. doi: 10.3390/v12080832
• [10] Łaniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. (2020) 17: 232–50. doi: 10.1038/s41585-020-0286-z
• [11] Leonardi M, Hicks C, El-Assaad F, El-Omar E, Condous G. Endometriosis and the microbiome: a systematic review. BJOG Int J Obstet Gynaecol. (2020) 127: 239–49. doi: 10.1111/1471-0528.15916
• [12] Li H, Zang Y, Wang C, Li H, Fan A, Han C. The interaction between microorganisms, metabolites, and immune system in the female genital tract microenvironment. Front Cell Infect Microbiol. (2020) 10: 609488. doi: 10.3389/fcimb.2020.609488
• [13] Madere FS, Monaco CL. The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease. Curr Opin Virol. (2022) 52: 15–23. doi: 10.1016/j.coviro.2021.10.010
• [14] Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, et al. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study. Sex Transm Infect. (2019) 95: 5–12. doi: 10.1136/sextrans-2017-053506
• [15] McKinnon LR, Achilles SL, Bradshaw CS, Burgener A, Crucitti T, Fredricks DN, et al. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res Hum Retroviruses. (2019) 35: 219–228. doi: 10.1089/aid.2018.0304
• [16] Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands: induction of pro-inflammatory cytokines by SCFAS. Am J Reprod Immunol. (2012) 67: 391–400. doi: 10.1111/j.1600-0897.2011.01089.x
• [17] Mohammadzadeh F, Dolatian M, Jorjani M, Majd HA. Diagnostic value of amsel's clinical criteria for diagnosis of bacterial vaginosis. Glob J Health Sci. (2015) 7: 8–14. doi: 10.5539/gjhs.v7n3p8
• [18] Pelzer ES, Willner D, Buttini M, Hafner LM, Theodoropoulos C, Huygens F. The fallopian tube microbiome: implications for reproductive health. Oncotarget. (2018) 9: 21541–51. doi: 10.18632/oncotarget.25059
• [19] Peric A, Weiss J, Vulliemoz N, Baud D, Stojanov M. Bacterial colonization of the female upper genital tract. Int J Mol Sci. (2019) 20: 3405. doi: 10.3390/ijms20143405
• [20] Sabo MC, Lehman DA, Wang B, Richardson BA, Srinivasan S, Osborn L, et al. Associations between vaginal bacteria implicated in HIV acquisition risk and pro-inflammatory cytokines and chemokines. Sex Transm Infect. (2020) 96: 3–9. doi: 10.1136/sextrans-2018-053949
• [21] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. The Lancet. (2021) 397: 839–52. doi: 10.1016/S0140-6736(21)00389-5
• [22] Villa P, Cipolla C, D'Ippolito S, Amar ID, Shachor M, Ingravalle F. The interplay between immune system and microbiota in gynecological diseases: a narrative review. Eur Rev Med Pharmacol Sci. (2020) 24: 5676–90. doi: 10.26355/eurrev_202005_21359
• [23] Vitali D, Wessels JM, Kaushic C. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract. AIDS Res Ther. (2017) 14: 39. doi: 10.1186/s12981-017-0169-4
• [24] Wessels JM, Domínguez MA, Leyland NA, Agarwal SK, Foster WG. Endometrial microbiota is more diverse in people with endometriosis than symptomatic controls. Sci Rep. (2021) 11: 18877. doi: 10.1038/s41598-021-98380-3
• [25] Wessels JM, Felker AM, Dupont HA, Kaushic C. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women. Dis Model Mech. (2018) 11: dmm035147. doi: 10.1242/dmm.035147
• [26] Yu B, Liu C, Fredricks D, Swisher E. Microbiome profiling of fallopian tubes. Gynecol Oncol. (2020) 156: e26. doi: 10.1016/j.ygyno.2019.11.085

• Document Type: article